Bayer Invites Global Researchers to Submit Novel Crop Protection Compounds Through New Testing4Ag Program
- Testing4Ag allows scientists to submit novel ideas for the company to test while those researchers and institutions retain all rights to any potential intellectual property.
- New program will leverage Bayer resources and expertise in collaboration with the world’s researchers to help develop future generations of crop protection chemistries.
MONHEIM, Germany, January 12, 2022 /3BLMedia/ – Bayer today announced the launch of Testing4Ag, a new program which allows research scientists from around the world to submit novel chemistries to Bayer for testing in hopes of identifing potential new modes of action to control fungal diseases, insect pests, or weeds. Testing4Ag, a part of Bayer’s Open4Ag partnership development and innovation approach, seeks to develop the newest generation of crop protection products that safely and sustainably address the changing needs of producers.
“Bayer is the leader in agricultural R&D and we are committed to driving the future of agriculture by delivering innovative and sustainable solutions to the problems facing farmers both today and tomorrow,” said Bob Reiter, Head of Research and Development at Bayer’s Crop Science Division. “Testing4Ag will combine the transformative ideas of pioneering researchers with Bayer’s knowledge, experts, and resources without taking ownership of the intellectual property participants contribute.”
Testing4Ag is executed in partnership with Halo and will help scientists learn more about their own compounds through testing and transparent results. The submitted compounds will be assessed via state-of-the-art biological testing against a wide variety of plant pathogens, weed species, insect and nematode pests, and/or vectors. Test results will be shared back directly with participants who can freely use them in continued research. In further commitment to open innovation, researchers and their institutions will retain all rights to the potential intellectual property generated through the Testing4Ag program.
“Testing4Ag is an ambitious program because developing crop protection products that help farmers feed the world in the face of climate change, while further reducing the environmental impact of agriculture is an ambitious goal,” said Rachel Rama, Head of Small Molecules at Bayer’s Crop Science Division. “Individual researchers, universities, even small startups can help add to our understanding of solutions to the most important problems facing agriculture right now. We welcome them to participate in Testing4Ag.”
To learn more about Testing4Ag, or to submit material for consideration, please visit www.Testing4Ag.com. Submissions must be received by March 31, 2022 in order to be eligible for consideration.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.
Charla Lord, phone +1 314 343 7196
Alexander Hennig, phone +49 175 3089736
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.